Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chemoimmunotherapy Plus Ratiotherapy for Extensive Stage Small-cell Lung Cancer

NCT06514118 is registered in ClinicalTrials.gov with Qingdao Central Hospital as lead sponsor.

NCT NCT06514118
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06514118 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chemoimmunotherapy Plus Ratiotherapy for Extensive Stage Small-cell Lung Cancer
Lead sponsor
Qingdao Central Hospital
Phase
Observational
Overall status
Recruiting
Start date
April 17, 2024
Completion date
March 16, 2027
Enrollment
70 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

radiation, residual tumor, small-cell lung cancer